Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.
about
The clinical impact of different coagulometers on patient outcomes.The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.The involvement of pharmacies in the screening of undiagnosed atrial fibrillation.Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy
P2860
Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@ast
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@en
type
label
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@ast
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@en
prefLabel
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@ast
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@en
P2093
P2860
P1476
Direct anticoagulant drugs to ...... atrial fibrillation patients.
@en
P2093
Alessandro Parolari
Anna Russolillo
Marina Camera
Matteo Nicola Dario Di Minno
P2860
P356
10.1517/14728214.2013.777427
P407
P577
2013-03-01T00:00:00Z